Omarigliptin, also known as MK-3102, is a potent, selective and long-acting dipeptidyl peptidase-4 (DPP-4) inhibitor. The Mechanism of action of MK-3102 CAS 1226781-44-7 is inhibiting DPP-4 to increase incretin levels (GLP-1 and GIP) which which in turn increases insulin secretion, decreases gastric emptying and decreases blood glucose levels. The Omarigliptin (MK-3102) CAS 1226781-44-7 is high specification and on sterile level with the molecular formula C17H20F2N4O3S and formula weight 398.43. We can offer effective service and arrange shipment in time

Thera. Category:Antidiabetic

Cas No.: 1226781-44-7

Synonyms: MK-3102;(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-(Methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-aMine;MK-3012;(2S,3R,5S)-2-(2,5-Difluorophenyl)-5-[2-(Methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-aMine (MK-3102 enantioMer);(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine;OMarigliptin;OMarigliptin (MK-3102);2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine MK3102

Molecular Formula: C17H20F2N4O3S

Molecular Weight: 398.43

Assay: ≥99%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

Usage:

Omarigliptin (MK-3102) is a potent, long-acting oral antidiabetic drug of the DPP-4 inhibitor class used for once-weekly treatment of type 2 diabetes and currently under development by Merck & Co.[1] It inhibits DPP-4 to increase incretin levels (GLP-1 and GIP),[2][3][4] which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying and decreases blood glucose levels.